title: New treatments for age-related macular degeneration.
authors.forename: Hugh R
authors.initials: HR
authors.lastname: Taylor
authors.forename: M Lynne
authors.initials: ML
authors.lastname: Pezzullo
authors.forename: Robyn
authors.initials: R
authors.lastname: Guymer
mesh_terms: D020533:Angiogenesis Inhibitors / Q000191:economics* / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000191:economics* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003362:Cost-Benefit Analysis; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy; D018803:Models, Economic; D011306:Prescription Fees; D000069579:Ranibizumab
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000069579:Ranibizumab